NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
NewcelX's total debt was $355.00K at Dec 31, 2025. For fiscal 2025 it was $355.00K, down 95.4% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $355.00K | -95.4% |
| FY2024 | Dec 31, 2024 | $7.73M | +5050.7% |
| FY2020 | Dec 31, 2020 | $150.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $355.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $7.73M | – |
| Q3 FY2024 | Oct 10, 2024 | $2.79M | – |
| Q4 FY2020 | Dec 31, 2020 | $150.00K | – |
See a number that looks wrong?